Navigation Links
Long-term spinal cord stimulation stalls symptoms of Parkinson's-like disease
Date:1/23/2014

DURHAM, N.C. -- Researchers at Duke Medicine have shown that continuing spinal cord stimulation appears to produce improvements in symptoms of Parkinson's disease, and may protect critical neurons from injury or deterioration.

The study, performed in rats, is published online Jan. 23, 2014, in the journal Scientific Reports. It builds on earlier findings from the Duke team that stimulating the spinal cord with electrical signals temporarily eased symptoms of the neurological disorder in rodents.

"Finding novel treatments that address both the symptoms and progressive nature of Parkinson's disease is a major priority," said the study's senior author Miguel Nicolelis, M.D., Ph.D., professor of neurobiology at Duke University School of Medicine. "We need options that are safe, affordable, effective and can last a long time. Spinal cord stimulation has the potential to do this for people with Parkinson's disease."

Parkinson's disease is caused by the progressive loss of neurons that produce dopamine, an essential molecule in the brain, and affects movement, muscle control and balance.

L-dopa, the standard drug treatment for Parkinson's disease, works by replacing dopamine. While L-dopa helps many people, it can cause side effects and lose its effectiveness over time. Deep brain stimulation, which emits electrical signals from an implant in the brain, has emerged as another valuable therapy, but less than 5 percent of those with Parkinson's disease qualify for this treatment.

"Even though deep brain stimulation can be very successful, the number of patients who can take advantage of this therapy is small, in part because of the invasiveness of the procedure," Nicolelis said.

In 2009, Nicolelis and his colleagues reported in the journal Science that they developed a device for rodents that sends electrical stimulation to the dorsal column, a main sensory pathway in the spinal cord carrying information from the body to the brain. The device was attached to the surface of the spinal cord in rodents with depleted levels of dopamine, mimicking the biologic characteristics of someone with Parkinson's disease. When the stimulation was turned on, the animals' slow, stiff movements were replaced with the active behaviors of healthy mice and rats.

Because research on spinal cord stimulation in animals has been limited to the stimulation's acute effects, in the current study, Nicolelis and his colleagues investigated the long-term effects of the treatment in rats with the Parkinson's-like disease.

For six weeks, the researchers applied electrical stimulation to a particular location in the dorsal column of the rats' spinal cords twice a week for 30-minute sessions. They observed a significant improvement in the rats' symptoms, including improved motor skills and a reversal of severe weight loss.

In addition to the recovery in clinical symptoms, the stimulation was associated with better survival of neurons and a higher density of dopaminergic innervation in two brain regions controlling movement the loss of which cause Parkinson's disease in humans. The findings suggest that the treatment protects against the loss or damage of neurons.

Clinicians are currently using a similar application of dorsal column stimulation to manage certain chronic pain syndromes in humans. Electrodes implanted over the spinal cord are connected to a portable generator, which produces electrical signals that create a tingling sensation to relieve pain. Studies in a small number of humans worldwide have shown that dorsal column stimulation may also be effective in restoring motor function in people with Parkinson's disease.

"This is still a limited number of cases, so studies like ours are important in examining the basic science behind the treatment and the potential mechanisms of why it is effective," Nicolelis said.

The researchers are continuing to investigate how spinal cord stimulation works, and are beginning to explore using the technology in other neurological motor disorders.


'/>"/>

Contact: Rachel Harrison
rachel.harrison@duke.edu
919-419-5069
Duke University Medical Center
Source:Eurekalert  

Related biology news :

1. Long-term research reveals causes and consequences of environmental change
2. Sexual reproduction brings long-term benefits, study shows
3. Long-term preservation: Pensoft Publishers partner with the CLOCKSS Archive
4. Model forecasts long-term impacts of forest land-use decisions
5. Study shows long-term effects of radiation in pediatric cancer patients
6. Is long-term weight loss possible after menopause?
7. New long-term antimicrobial catheter developed
8. Preeclampsia poses a significant long-term health risk according to new research from Ben-Gurion U.
9. Preemies brains reap long-term benefits from Kangaroo Mother Care
10. Site-specific, long-term research expanding understanding of climate change
11. Tsunami caused long-term ecosystem change in the Caribbean
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Long-term spinal cord stimulation stalls symptoms of Parkinson's-like disease
(Date:11/19/2016)... -- Securus Technologies, a leading provider of civil and ... and monitoring, announced today that it has offered a ... independent technology judge determine who has the largest and ... calling platform, and the best customer service. ... what we do – which clearly is not the ...
(Date:11/15/2016)... Research and Markets has announced the addition ... report to their offering. ... The global ... from USD 6.21 Billion in 2016, growing at a CAGR of ... bioinformatics market is driven by the growing demand for nucleic acid ...
(Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... -- CytRx Corporation (NASDAQ: CYTR ), a ... announced the appointment of Earl Warren Brien , ... healthcare investor, to its Board of Directors. ... strategic experience at the highest level," said Steven ... of the world,s leading orthopedic surgeons, Dr. Brien has ...
(Date:12/2/2016)... ... December 01, 2016 , ... ACEA Biosciences, Inc. announced today ... clinical trials for AC0010 at the World Conference on Lung Cancer 2016, taking place ... on the phase I/II clinical trials for AC0010 in patients with advanced non-small cell ...
(Date:12/2/2016)... ... December 01, 2016 , ... Aerocom Healthcare ... American hospitals, will present its chain-of-custody solution for tracking and securing medications at ... Nev., Dec. 4-8, 2016. , Aerocom has a proven solution for tracking medications ...
(Date:12/2/2016)... ... December 01, 2016 , ... The Conference Forum has announced that ... and will take place on February 1-3, 2017 at the Roosevelt Hotel in New ... the program provides a unique 360-degree approach, which addresses the most up-to-date information regarding ...
Breaking Biology Technology: